HealthcareServices

Global Metagenomic Sequencing Industry Insights: Key Trends and Growth Estimates

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the metagenomic sequencing market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Metagenomic Sequencing Market expected to reach by 2030?

The metagenomic sequencing market has experienced swift expansion in recent years. This market is set to increase from $2.5 billion in 2025 to $2.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.1%. Historically, this growth can be ascribed to the escalating use of NGS, the early uptake of microbial community studies, a rising demand for DNA extraction kits, the development in environmental microbiology research, and the broadening of clinical diagnostics.

The metagenomic sequencing market is anticipated to experience swift expansion in the upcoming years. This market is projected to reach $5.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. Factors driving this growth over the forecast period include advancements in sequencing technologies, the expansion of microbiome-based therapeutics, increased investment in bioinformatics, growing demand for cloud-based genomic analysis, and the broader application of precision medicine. Key trends anticipated during this period encompass the spread of precision genomics via high-throughput sequencing, AI-powered metagenomic data analysis, the automation of sample preparation and sequencing processes, the use of cloud-based bioinformatics platforms for managing large datasets, and IoT-enabled environmental microbiome monitoring.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

What Drivers Are Driving Adoption Within The Metagenomic Sequencing Market?

The increasing prevalence of tuberculosis (TB) is anticipated to fuel the expansion of the metagenomic sequencing market in the future. TB, an infectious ailment caused by Mycobacterium tuberculosis, mainly impacts the lungs and spreads via airborne droplets released when infected people cough or sneeze. The rise in TB incidents can be attributed to elements like worldwide migration, compromised immune systems, resistance to antimicrobials, and deficiencies in public health monitoring. Metagenomic sequencing aids in TB identification by allowing for quick, impartial pathogen detection, uncovering drug-resistance genes, and enhancing outbreak surveillance, which is vital for handling emerging infectious challenges. For example, data from March 2024, provided by the US-based government agency, Centers for Disease Control and Prevention, indicated an escalation in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Consequently, the growing concern of tuberculosis is stimulating the development of the metagenomic sequencing market.

What Segments Are Included Within The Metagenomic Sequencing Market?

The metagenomic sequencing market covered in this report is segmented –

1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions

2) By Technology: 16S RNA Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics

3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications

Subsegments:

1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)

2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments

3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing

4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms

Which Trends Are Influencing The Performance And Direction Of The Metagenomic Sequencing Market?

Major companies operating in the metagenomic sequencing market are prioritizing the innovation of sequencing services to enhance their accuracy, throughput, and cost-effectiveness. These sequencing services represent advanced genomic technologies designed to sequence longer DNA fragments, thereby providing a more comprehensive understanding of genetic structures compared to traditional short-read methodologies. For instance, in April 2024, Clinical Microbiomics A/S, a Denmark-based biotechnology company, unveiled advanced long-read sequencing services. These services include 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics, which collectively offer unparalleled resolution and quality in microbial analysis, facilitating detailed insights into microbial communities and supporting the creation of high-quality metagenome-assembled genomes.

Who Are The Major Companies Operating In The Metagenomic Sequencing Market?

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Which Regions Are Poised For Strategic Growth In The Metagenomic Sequencing Market?

North America was the largest region in the metagenomic sequencing market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Metagenomic Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16117&type=smp

Browse Through More Reports Similar to the Global Metagenomic Sequencing Market 2026, By The Business Research Company

Protein Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Metagenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795